Client Result
Orrick Advises Turn/River Capital on its Sale of Redwood Software to Vista Equity Partners and Warburg Pincus
2 minute read | September.10.2024
2 minute read | September.10.2024
2 minute read | February.14.2024
Turn/River Capital has sold CoSoSys to Netwrix Corporation, a cybersecurity vendor focused on data security. Orrick represented Turn/River Capital.
1 minute read | September.08.2023
by Zac Padgett, Daniel Lopez, Richard Smith and Nnaemeka K. Anyanwu
5 minute read | May.22.2023
August.02.2022
June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
December.20.2021
July.15.2021
June.25.2021
January.22.2021
January.08.2021
April.24.2019